The role of NADPH oxidase 1-derived reactive oxygen species in paraquat-mediated dopaminergic cell death.

Oxidative stress is the common downstream effect of a variety of environmental neurotoxins that are strongly implicated in the pathogenesis of Parkinson's disease. We demonstrate here that the activation of NADPH oxidase 1 (Nox1), a specialized superoxide-generating enzyme complex, plays a key role in the oxidative stress and subsequent dopaminergic cell death elicited by paraquat. Paraquat increased the expression of Nox1 in a concentration-dependent manner in rat dopaminergic N27 cells. Rac1, a key component necessary for Nox1-mediated superoxide generation, also was activated by paraquat. Paraquat-induced reactive oxygen species generation and dopaminergic cell death were significantly reduced after pretreatment with apocynin, a putative NADPH oxidase inhibitor, and Nox1 knockdown with siRNA. Male C57BL/6 mice received intraperitoneal (IP) injections of paraquat (10 mg/kg) once every 3 days and showed increased Nox1 levels in the substantia nigra as well as a 35% reduction in tyrosine hydroxylase-positive dopaminergic neurons 5 days after the last injection. Preadministration of apocynin (200 mg/kg, IP) led to a significant decrease in dopaminergic neuronal loss. Our results suggest that Nox1-generated superoxide is implicated in the oxidative stress elicited by paraquat in DA cells, and it can serve as a novel target for pharmacologic intervention.

[1]  G. Bokoch,et al.  Current molecular models for NADPH oxidase regulation by Rac GTPase. , 2002, Blood.

[2]  R. Busse,et al.  Apocynin Is Not an Inhibitor of Vascular NADPH Oxidases but an Antioxidant , 2008, Hypertension.

[3]  J. Dumont,et al.  Cloning of Two Human Thyroid cDNAs Encoding New Members of the NADPH Oxidase Family* , 2000, The Journal of Biological Chemistry.

[4]  E. Gazzano,et al.  Classical inhibitors of NOX NAD(P)H oxidases are not specific. , 2008, Current drug metabolism.

[5]  J. Andersen,et al.  Superoxide Dismutase/Catalase Mimetics Are Neuroprotective against Selective Paraquat-mediated Dopaminergic Neuron Death in the Substantial Nigra , 2005, Journal of Biological Chemistry.

[6]  J. Langston,et al.  Environmental Risk Factors and Parkinson's Disease: Selective Degeneration of Nigral Dopaminergic Neurons Caused by the Herbicide Paraquat , 2002, Neurobiology of Disease.

[7]  C. Yabe-Nishimura,et al.  PKCδ mediates up-regulation of NOX1, a catalytic subunit of NADPH oxidase, via transactivation of the EGF receptor: possible involvement of PKCδ in vascular hypertrophy , 2005 .

[8]  Seung U. Kim,et al.  Inhibition of thrombin‐induced microglial activation and NADPH oxidase by minocycline protects dopaminergic neurons in the substantia nigra in vivo , 2005, Journal of neurochemistry.

[9]  C. Yabe-Nishimura,et al.  NOX1/NADPH oxidase negatively regulates nerve growth factor-induced neurite outgrowth. , 2006, Free radical biology & medicine.

[10]  M. Geiszt,et al.  Involvement of Rac1 in Activation of Multicomponent Nox1- and Nox3-Based NADPH Oxidases , 2006, Molecular and Cellular Biology.

[11]  Y. Agid,et al.  Nitric oxide synthase and neuronal vulnerability in parkinson's disease , 1996, Neuroscience.

[12]  J. Lambeth,et al.  Nox1-dependent Reactive Oxygen Generation Is Regulated by Rac1* , 2006, Journal of Biological Chemistry.

[13]  D. Godin,et al.  Parkinson's disease: A disorder due to nigral glutathione deficiency? , 1982, Neuroscience Letters.

[14]  A. H. V. Schapira,et al.  MITOCHONDRIAL COMPLEX I DEFICIENCY IN PARKINSON'S DISEASE , 1989, The Lancet.

[15]  L. Rushton,et al.  Pesticides and Parkinson’s Disease—Is There a Link? , 2005, Environmental Health Perspectives.

[16]  Wei Zhang,et al.  The role of microglia in paraquat-induced dopaminergic neurotoxicity. , 2005, Antioxidants & redox signaling.

[17]  J. Bus,et al.  Paraquat: model for oxidant-initiated toxicity. , 1984, Environmental health perspectives.

[18]  Y. Suh,et al.  Cell transformation by the superoxide-generating oxidase Mox1 , 1999, Nature.

[19]  C. Marsden,et al.  Increased Nigral Iron Content and Alterations in Other Metal Ions Occurring in Brain in Parkinson's Disease , 1989, Journal of neurochemistry.

[20]  S. Przedborski,et al.  Oxidative Stress in Parkinson's Disease , 2008, Annals of the New York Academy of Sciences.

[21]  C. Yabe-Nishimura,et al.  The AP-1 site is essential for the promoter activity of NOX1/NADPH oxidase, a vascular superoxide-producing enzyme: Possible involvement of the ERK1/2-JunB pathway. , 2008, Biochemical and biophysical research communications.

[22]  A Ghetti,et al.  Lifestyle‐related risk factors for Parkinson's disease: a population‐based study , 2003, Acta neurologica Scandinavica.

[23]  M. Duchen,et al.  Expression and Modulation of an NADPH Oxidase in Mammalian Astrocytes , 2005, The Journal of Neuroscience.

[24]  C. Hertzman,et al.  Parkinson's disease: a case-control study of occupational and environmental risk factors. , 1990, American journal of industrial medicine.

[25]  Jung-Ae Kim,et al.  Rac1-NADPH oxidase-regulated generation of reactive oxygen species mediates glutamate-induced apoptosis in SH-SY5Y human neuroblastoma cells , 2005, Free radical research.

[26]  D. Harrison,et al.  Angiotensin II-mediated hypertension in the rat increases vascular superoxide production via membrane NADH/NADPH oxidase activation. Contribution to alterations of vasomotor tone. , 1996, The Journal of clinical investigation.

[27]  D. Graham Oxidative pathways for catecholamines in the genesis of neuromelanin and cytotoxic quinones. , 1978, Molecular pharmacology.

[28]  Erwin G. Van Meir,et al.  Homologs of gp91phox: cloning and tissue expression of Nox3, Nox4, and Nox5. , 2001, Gene.

[29]  G. Cohen,et al.  Free radical mediated cell toxicity by redox cycling chemicals. , 1987, The British journal of cancer. Supplement.

[30]  A. Sun,et al.  Cytotoxicity of paraquat in microglial cells: Involvement of PKCδ- and ERK1/2-dependent NADPH oxidase , 2007, Brain Research.

[31]  V. Uversky,et al.  The Herbicide Paraquat Causes Up-regulation and Aggregation of α-Synuclein in Mice , 2002, The Journal of Biological Chemistry.

[32]  Gang-yi Wu,et al.  Synaptic localization of a functional NADPH oxidase in the mouse hippocampus , 2005, Molecular and Cellular Neuroscience.

[33]  Todd B. Sherer,et al.  Subcutaneous Rotenone Exposure Causes Highly Selective Dopaminergic Degeneration and α-Synuclein Aggregation , 2003, Experimental Neurology.

[34]  E. Klann,et al.  NADPH oxidase immunoreactivity in the mouse brain , 2003, Brain Research.

[35]  K. Jellinger,et al.  Reduced and oxidized glutathione in the substantia nigra of patients with Parkinson's disease , 1992, Neuroscience Letters.

[36]  V. Uversky,et al.  The herbicide paraquat causes up-regulation and aggregation of alpha-synuclein in mice: paraquat and alpha-synuclein. , 2002, The Journal of biological chemistry.

[37]  T. Neumann-Haefelin,et al.  NADPH Oxidase Plays a Central Role in Blood-Brain Barrier Damage in Experimental Stroke , 2007, Stroke.

[38]  T. Montine,et al.  Parkinson's disease is associated with oxidative damage to cytoplasmic DNA and RNA in substantia nigra neurons. , 1999, The American journal of pathology.

[39]  J. Andersen,et al.  Role of oxidative stress in paraquat‐induced dopaminergic cell degeneration , 2005, Journal of neurochemistry.

[40]  Dong-Hoon Shin,et al.  Immunohistochemical study of p47Phox and gp91Phox distributions in rat brain , 2005, Brain Research.

[41]  A. McCormack,et al.  Microglial activation as a priming event leading to paraquat-induced dopaminergic cell degeneration , 2007, Neurobiology of Disease.

[42]  C. Yabe-Nishimura,et al.  PKCdelta mediates up-regulation of NOX1, a catalytic subunit of NADPH oxidase, via transactivation of the EGF receptor: possible involvement of PKCdelta in vascular hypertrophy. , 2005, The Biochemical journal.

[43]  N. Cairns,et al.  Apocynin improves outcome in experimental stroke with a narrow dose range , 2008, Neuroscience.

[44]  M. Beal Mitochondria, Oxidative Damage, and Inflammation in Parkinson's Disease , 2003, Annals of the New York Academy of Sciences.

[45]  S. Lorenzl,et al.  A pivotal role of matrix metalloproteinase‐3 activity in dopaminergic neuronal degeneration via microglial activation , 2007, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[46]  Keshav K. Singh,et al.  Cross talk between mitochondria and superoxide generating NADPH oxidase in breast and ovarian tumors , 2005, Cancer biology & therapy.

[47]  P D Griffiths,et al.  Iron in the basal ganglia in Parkinson's disease. An in vitro study using extended X-ray absorption fine structure and cryo-electron microscopy. , 1999, Brain : a journal of neurology.

[48]  F. Rossi,et al.  Biochemical aspects of phagocytosis in poly-morphonuclear leucocytes. NADH and NADPH oxidation by the granules of resting and phagocytizing cells , 1964, Experientia.

[49]  C. Marsden,et al.  Basal Lipid Peroxidation in Substantia Nigra Is Increased in Parkinson's Disease , 1989, Journal of neurochemistry.

[50]  A. Kanthasamy,et al.  Pharmacological inhibition of neuronal NADPH oxidase protects against 1-methyl-4-phenylpyridinium (MPP+)-induced oxidative stress and apoptosis in mesencephalic dopaminergic neuronal cells. , 2007, Neurotoxicology.

[51]  Manisha N. Patel,et al.  Mitochondria Are a Major Source of Paraquat-induced Reactive Oxygen Species Production in the Brain* , 2007, Journal of Biological Chemistry.

[52]  H. Um,et al.  Link between Mitochondria and NADPH Oxidase 1 Isozyme for the Sustained Production of Reactive Oxygen Species and Cell Death* , 2006, Journal of Biological Chemistry.

[53]  Colin L. Masters,et al.  Neurodegenerative diseases and oxidative stress , 2004, Nature Reviews Drug Discovery.

[54]  Gary W Miller,et al.  Paraquat neurotoxicity is distinct from that of MPTP and rotenone. , 2005, Toxicological sciences : an official journal of the Society of Toxicology.

[55]  H. Paulson,et al.  SOD1 mutations disrupt redox-sensitive Rac regulation of NADPH oxidase in a familial ALS model. , 2008, The Journal of clinical investigation.

[56]  Manisha Patel,et al.  Role of reactive oxygen species in the neurotoxicity of environmental agents implicated in Parkinson's disease. , 2008, Free radical biology & medicine.

[57]  A. Lees,et al.  A Generalised Increase in Protein Carbonyls in the Brain in Parkinson's but Not Incidental Lewy Body Disease , 1997, Journal of neurochemistry.

[58]  K. Sango,et al.  Reactive Oxygen Species Derived from NOX1/NADPH Oxidase Enhance Inflammatory Pain , 2008, The Journal of Neuroscience.

[59]  Bin Liu,et al.  Critical Role for Microglial NADPH Oxidase in Rotenone-Induced Degeneration of Dopaminergic Neurons , 2003, The Journal of Neuroscience.

[60]  R. Davisson,et al.  NADPH oxidases of the brain: distribution, regulation, and function. , 2006, Antioxidants & redox signaling.

[61]  Kevin L Quick,et al.  Ketamine-Induced Loss of Phenotype of Fast-Spiking Interneurons Is Mediated by NADPH-Oxidase , 2007, Science.